GENNARELLI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 15.933
EU - Europa 6.447
AS - Asia 4.147
AF - Africa 24
SA - Sud America 23
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 21
AN - Antartide 1
Totale 26.617
Nazione #
US - Stati Uniti d'America 15.880
CN - Cina 2.280
UA - Ucraina 1.932
PL - Polonia 1.070
IT - Italia 875
DE - Germania 832
SG - Singapore 746
HK - Hong Kong 565
FI - Finlandia 437
FR - Francia 419
GB - Regno Unito 390
IE - Irlanda 321
TR - Turchia 314
IN - India 95
VN - Vietnam 68
CA - Canada 48
BE - Belgio 39
SE - Svezia 35
CZ - Repubblica Ceca 31
ID - Indonesia 25
EU - Europa 21
AU - Australia 20
BR - Brasile 19
IR - Iran 16
NL - Olanda 16
ZA - Sudafrica 10
CH - Svizzera 9
SA - Arabia Saudita 9
MU - Mauritius 7
RU - Federazione Russa 7
KR - Corea 6
RO - Romania 6
BG - Bulgaria 5
ES - Italia 5
JP - Giappone 5
EG - Egitto 4
IL - Israele 4
LT - Lituania 4
HU - Ungheria 3
LU - Lussemburgo 3
PK - Pakistan 3
AT - Austria 2
HN - Honduras 2
JO - Giordania 2
MA - Marocco 2
PA - Panama 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
CL - Cile 1
EC - Ecuador 1
EE - Estonia 1
GR - Grecia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
TH - Thailandia 1
TN - Tunisia 1
Totale 26.617
Città #
Fairfield 2.491
Woodbridge 1.991
Jacksonville 1.428
Houston 1.264
Ashburn 1.129
Ann Arbor 1.076
Warsaw 1.070
Cambridge 1.007
Seattle 921
Wilmington 825
Chandler 654
Singapore 611
Princeton 602
Hong Kong 562
Nanjing 516
Dublin 317
Beijing 289
Istanbul 280
Brescia 270
New York 244
Dearborn 230
Nanchang 210
Helsinki 192
Des Moines 158
Shenyang 153
Hebei 139
San Diego 131
Changsha 126
Lancaster 100
Jinan 99
Shanghai 96
Milan 92
Jiaxing 83
Tianjin 83
Dong Ket 68
Kunming 63
Verona 60
Norwalk 57
Boardman 54
Munich 54
Hangzhou 53
Los Angeles 49
Lanzhou 48
Zhengzhou 48
Ningbo 47
London 42
Brussels 38
Haikou 38
Romola 34
San Mateo 34
Bolzano 32
San Francisco 30
Leawood 27
Brno 26
Guangzhou 24
Jakarta 24
Kocaeli 24
Toronto 23
Washington 22
Fuzhou 21
Augusta 19
Changchun 18
Hefei 18
Orange 17
Kilburn 16
Taizhou 16
Ardabil 14
Naples 13
Taiyuan 12
Rome 11
Chiswick 9
Hounslow 9
Frankfurt am Main 8
Lappeenranta 8
Phoenix 8
Québec 8
San Donà Di Piave 8
Chicago 7
Redwood City 7
Basel 6
Bela-Bela 6
Canberra 6
Falkenstein 6
Guastalla 6
New Bedfont 6
Casalmaggiore 5
Chengdu 5
Crotone 5
Mantova 5
Markham 5
Monmouth Junction 5
Ottawa 5
Redmond 5
Riyadh 5
Acton 4
Ansbach 4
Chongqing 4
Gunzenhausen 4
Melbourne 4
Montreal 4
Totale 20.810
Nome #
New Copy Number Variations in Schizophrenia 268
Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling 265
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 264
The effect of childhood trauma on blood transcriptome expression in major depressive disorder 223
Compound heterozygosity for a large CNV deletion and a rare missense mutation in the FSTL5 gene of a patient affected by schizophrenia. 216
Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease. 204
Compound heterozygosity for a hemizygous rare missense variant (rs141999351) and a large CNV deletion affecting the FSTL5 gene in a patient with schizophrenia 179
Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables 176
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 169
Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans. 162
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood 161
New biological pathways for major depression: gene expression decomposition in G x E components 161
Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients 159
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 158
Copy number variants in attention-deficit hyperactive disorder: identification of the 15q13 deletion and its functional role. 153
Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation 147
Genomic restricted maximum likelihood (GREML) analysis to estimate the heritability of response/resistance in major depressive disorder (MDD) 146
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. 145
The role of the potassium channel gene KCNK2 in major depressive disorder 145
Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. 145
TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. 140
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 140
The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study. 135
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 134
Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder 132
Gene per la neuregulina 1 e schizofrenia: ulteriori evidenze di associazione 131
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 128
Next Generation Sequencing Analysis in Early Onset Dementia Patients 127
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 126
Acute Stress Responsiveness of the Neurotrophin BDNF in the Rat Hippocampus is Modulated by Chronic Treatment with the Antidepressant Duloxetine. 125
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 124
Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia 123
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD 123
3' UTR (AGG)n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia. 120
A genome-wide investigation of SNPs and CNVs in schizophrenia. 120
5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression 120
The Expression of VGF is Reduced in Leukocytes of Depressed Patients and it is Restored by Effective Antidepressant Treatment 120
MTHFR: Genetic variants, expression analysis and COMT interaction in major depressive disorder 120
Glucose metabolism alterations in patients with bipolar disorder 120
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 118
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 117
Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline 'Predictors' and Longitudinal 'Targets' 117
The Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders 115
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 114
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects. 114
ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder. 113
A putative regulatory subunit (NR3A) of the NMDA receptor complex as candidate gene for susceptibility to schizophrenia: a case-control study. 113
Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders. 113
BDNF Val66Met polymorphism and protein levels in amniotic fluid. 112
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 112
TWO PEDIGREES OF AUTOSOMAL DOMINANT ATRIOVENTRICULAR CANAL DEFECT (AVCD): EXCLUSION FROM THE CRITICAL REGION ON 8p. 111
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients. 111
Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. 111
Possible Influence of a Non-Synonymous Polymorphism Located in the NGF Precursor on Susceptibility to Late-Onset Alzheimer's Disease and Mild Cognitive Impairment. 111
The role of GRIK4 gene in treatment-resistant depression 111
The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia 110
STUDY OF THE EFFECTS ON DNA OF ELECTROMAGNETIC FIELDS USING CLAMPED HOMOGENEOUS ELECTRIC FIELD GEL ELECTROPHORESIS. 109
Alterations of Brain-Derived Neurotrophic Factor Serum Levels in Patients with Alcohol Dependence. 109
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients 109
Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. 108
Seizure Adequacy Markers and the Prediction of Electroconvulsive Therapy Response 108
Functional study of a novel homozygous mutation in the GAD1 gene, detected in a patient with schizophrenia. 108
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. 107
Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: a case-control study. 106
Polymorphic CA repeat in IGF-I gene: lack of association with schizophrenia. 106
Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series 106
Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study. 105
Prediction of myotonic dystrophy clinical severity based on the number of intragenic [CTG]n trinucleotide repeats. 104
An association of GRIK3 Ser310Ala functional polymorphism with personality traits. 104
Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: Comparison with methylphenidate. 104
The influence of psychiatric screening in healthy populations selection: a new study and meta-analysis of functional 5-HTTLPR and rs25531 polymorphisms and anxiety-related personality traits. 104
INFLAMMATORY AND NEUROTROPHIC FACTORS UNBALANCE IN LEUKOCYTES OF FIRST EPISODE PSYCHOSIS PATIENTS 104
Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. 104
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 104
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 104
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 104
Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. 104
Clinical and medial temporal features in a family with mood disorders. 103
Heterozygous TREM2 mutations in frontotemporal dementia 103
GENOTYPING OF SPINAL MUSCULAR ATROPHY FAMILIES WITH LINKED DNA PROBES. 102
CTG repeats distribution and Alu insertion polymorphism at myotonic dystrophy (DM) gene in Amhara and Oromo populations of Ethiopia 102
VEGF Haplotypes are Associated with Increased Risk to Progressive Supranuclear Palsy and Corticobasal Syndrome. 102
Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients 102
Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels 101
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 100
MEIOTIC DRIVE AT THE MYOTONIC DYSTROPHY LOCUS. 100
A single polymerase chain reaction-based protocol for detecting normal and expanded alleles in myotonic dystrophy. 100
Long-Term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms. 100
Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus 100
Genetic Variation in the G720/G30 Gene Locus (DAOA) Influences the Occurrence of Psychotic Symptoms in Patients with Alzheimer's Disease. 100
MALE HYPOGONADISM IN MYOTONIC DYSTROPHY IS RELATED TO (CTG)n TRIPLET MUTATION. 99
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 99
Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol. 99
Immune and metabolic alterations in first episode psychosis (FEP) patients 99
α-Synuclein and Glia in Parkinson’s Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System? 99
Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. 98
Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients. 98
Genetic variations and association. 98
Influence of GRIK4 genetic variants on the electroconvulsive therapy response 98
EXPANSION OF THE MYOTONIC DYSTROPHY GENE IN ITALIAN AND SPANISH PATIENTS 97
Totale 12.497
Categoria #
all - tutte 138.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.869


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.422 0 0 0 0 461 905 743 891 563 902 530 427
2020/20214.626 105 495 186 537 220 500 213 513 683 414 550 210
2021/20222.396 158 541 56 56 14 98 206 142 172 238 206 509
2022/20232.084 349 12 31 146 190 620 6 208 315 32 94 81
2023/20242.135 127 52 188 131 95 349 60 72 588 37 37 399
2024/20251.379 47 55 82 615 580 0 0 0 0 0 0 0
Totale 27.109